KAITLYN CARMO: Open Payments
NPI 1417608266 · CHESTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,028 in 38 payments from 16 companies in 2025. Trend: 2023 $788 · 2024 $3,004 · 2025 $1,028
Food & beverage: $1,028
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $190 |
| Abbott Laboratories | 1 | $147 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $107 |
| AGEPHA Pharma FZ LLC | 1 | $100 |
| PFIZER INC. | 4 | $83 |
| Novartis Pharmaceuticals Corporation | 3 | $65 |
| SCPHARMACEUTICALS INC. | 2 | $64 |
| Kestra Medical Technology Services, Inc. | 3 | $64 |
| Amgen Inc. | 3 | $45 |
| Esperion Therapeutics, Inc. | 2 | $36 |
Products named: Wegovy, CARDIOMEMS, JARDIANCE, LODOCO, VYNDAQEL, LEQVIO, FUROSCIX, Assure WCD.
Industry payments across PA — which companies pay providers there.
